PACKAGE LEAFLET: INFORMATION FOR THE USER. Xylo-COMOD
|
|
- Irene Strickland
- 6 years ago
- Views:
Transcription
1 PACKAGE LEAFLET: INFORMATION FOR THE USER Xylo-COMOD Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to use Xylo-COMOD carefully to get the best results from it. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must contact a doctor if your symptoms worsen or do not improve after 7 days. - If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Xylo-COMOD is and what it is used for 2. Before you use Xylo-COMOD 3. How to use Xylo-COMOD 4. Possible side effects 5. How to store Xylo-COMOD 6. Further information 1. WHAT XYLO-COMOD IS AND WHAT IT IS USED FOR Xylo-COMOD is a medicinal product for nasal application (nasal preparation) which contains the alpha-sympathomimetic agent xylometazoline. Xylometazoline has vasoconstrictive properties and thus effects decongestion of the nasal mucosa. Xylo-COMOD is used for - short term treatment in case of congestion of the nasal mucosa. Xylo-COMOD is intended for use by adults and school children. 2. BEFORE YOU USE XYLO-COMOD Do not use Xylo-COMOD in case of - hypersensitivity to xylometazoline hydrochloride or to any of the excipients of Xylo- COMOD, - dry inflammation of the nasal mucosa (rhinitis sicca), - after pinealectomy through the nose or other surgical interventions laying bare the dura mater, - babys and children under the age of 6 years.
2 Take special care with Xylo-COMOD Babies and young infants should be treated with special care. In single cases, severe side effects (particularly apnoea) have been reported after administration of the recommended dose in this age group. Overdose must unconditionally be avoided. In case of the following diseases and situations, Xylo-COMOD must be used only after consultation of your doctor: - elevated intraocular pressure, particularly narrow-angle glaucoma, - severe cardiovascular diseases (e.g. coronary heart disease) and hypertension, - in case you take mono-amino oxidase inhibitors (MAO inhibitors) or other drugs which potentially increase the blood pressure - if you suffer from a tumor of the suprarenal gland (pheochromocytoma) - metabolic disorders (e.g. hyperthyroidism and diabetes) - prostata enlargement - porphyria Permanent use of decongestive nasal preparations agents may lead to chronical swelling and finally atrophy of the nasal mucosa. Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without prescription. The concomittant use of Xylo-COMOD and certain antidepressant medicinal products (monoamino oxidase (MAO-) inhibitors of the tranylcypromine type or tricyclic antidepressants) and hypertensive drugs can lead to an increased blood pressure. Please consider that this might apply as well for medicinal products which were used recently. Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. Since there are only limited data available on the safety profile of Xylo-COMOD during pregnancy and breast-feeding, Xylo-COMOD must only be used during pregnancy and breast feeding after advice by your doctor and after a careful consideration of benefit and risk through your doctor. The recommended dose must not be exceeded during pregnancy and breast feeding, as overdosing can impair the blood supply of the unborn child and might reduce the production of breast milk. Driving and using machines If used as recommended, no adverse effects are to be expected.
3 3. HOW TO USE XYLO-COMOD Always use Xylo-COMOD exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The usual dose is: Adults and children above the age of 6 years apply one spray of Xylo-COMOD into each nostril up to three times a day. Mode of administration: Xylo-COMOD is intended only for local administration to the nose. Remove the protective cap (1) before first use. Hold the spray flask as shown and press the pump mechanism until a fine spray is emitted. Insert the nose adapter ("nozzle") (2) into each nostril and apply one spray into each nostril. In order to avoid solidification of the solution within the pump mechanism, the protective cover should be attached again after each usage. Duration of treatment: Xylo-COMOD should not be used longer than 7 days without consultation of a doctor. A renewed administration should take place only after a therapy-free interval of a couple of days. Use during chronic cold must be controlled by a doctor due to the risk of atrophy of the nasal mucosa. Please speak to your doctor or pharmacist if you feel that the effect of Xylo-COMOD is too strong or too weak. If you use more Xylo-COMOD than you should, please inform your doctor immediately. Intoxications can occur after excessive overdosing or due to intake of the medicinal product by mistake. The clinical picture of intoxication with Xylo-COMOD can be confusing, since periods of stimulation can alternate with periods of depression of the central nervous system and of the cardiovascular system. Especially in children, overdose can cause dominating central effects with convulsions and coma, bradycardia, apnoea as well as hypertension, which can alternate with hypotension.
4 Signs of a stimulation of the central nervous system are anxiety, excitement, hallucinations and convulsions. Signs of a depression of the central nervous system are: reduced blood heat, lethargy, sleepiness and coma. The following other symptoms can occur: miosis, mydriasis, fever, sweating, paleness, cyanosis, palpitation, respiratory depression and apnoea, sickness and nausea, psychogenic disturbances, hypertonia, hypotonia, cardiac arrhythmia, tachycardia, bradycardia. In case of intoxication, a doctor must be informed immediately, monitoring and control of the affected patient in a hospital is necessary. If you forget to use Xylo-COMOD Do not administer more than 1 spray in each nostril in case that you forgot the last administration. Rather, please continue with the administration as recommended. If you have any questions on the use of this product please ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Xylo-COMOD can cause side effects, although not everybody gets them. For the assessment of side effects the following frequencies of occurrence are defined: Very common: more than 1 of 10 treated patients Common: 1 to 10 of 100 treated patients Uncommon: 1 to 10 of 1000 treated patients Rare: 1 to 10 of treated patients Very rare: less than 1 of treated patients Not known: frequency on basis of the available data not assessable Nervous system: Very rare: restlessness, insomnia, tiredness (sleepiness, sedation), headache, hallucinations (particularly in children) Cardiovascular system: Rare: palpitations, tachycardia, increase in blood pressure Very rare: cardiac arrhythmia Respiratory tracts: Common: burning or dryness of the nasal mucosa, sneezing Uncommon: experience of an increased swelling of the mucosa after subsiding of the effect, nose bleeding Muscular and skeletal system: Very rare: convulsions (particularly in children) Immune system: Uncommon: hypersensitivity reactions (angioedema, exanthema, itching)
5 If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE XYLO-COMOD Keep out of the reach and sight of children. Do not use Xylo-COMOD after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month. Storage conditions Do not store above 25 C. Shelf life after opening: Xylo-COMOD can be used for 8 weeks after first opening. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Xylo-COMOD contains The active substance is xylometazoline hydrochloride. The other ingredients are disodium edetate (Ph.Eur.); sodium dihydrogen phosphate dihydrate; disodium phosphate dodecahydrate (Ph.Eur.); sorbitol (Ph.Eur.); purified water. What Xylo-COMOD looks like and contents of the pack Xylo-COMOD is a clear, colourless solution, filled in a multiple dose container with gas-free pump-system. A pre-package contains one bottle with 15 ml of solution. Marketing Authorisation Holder and Manufacturer URSAPHARM Industriestraße Saarbrücken Tel: (+49) (0)6805/ Fax: (+49) (0)6805/ info@ursapharm.de This leaflet was last approved in May 2007.
Read all of this leaflet carefully before you start using this medicine.
PACKAGE LEAFLET: INFORMATION FOR THE USER Allergo-COMOD nasal spray 20 mg/ml Nasal spray, solution Active ingredient: sodium cromoglicate (Ph. Eur.) 1 spray of 0.14 ml of Allergo-COMOD nasal spray contains
More informationPATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml
PATIENT INFORMATION LEAFLET Nasoxyl nasal spray solution 1 mg/ml Read all of this leaflet carefully, because it contains important information for you. This medicine is available without prescription.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride Read all of this leaflet carefully before you start using this
More informationPackage leaflet: Information for the patient. xylometazoline hydrochloride
Package leaflet: Information for the patient /.../ 0.5 mg/ml nasal spray, solution /.../ 1 mg/ml nasal spray, solution xylometazoline hydrochloride Read all of this leaflet carefully before you start using
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Xylonase 0.1% w/v Nasal Spray, Solution Xylometazoline hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Xylonase 0.1% w/v Nasal Spray, Solution Xylometazoline hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Nasonal 1 mg/ml neusspray, oplossing. Xylometazoline hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Nasonal 1 mg/ml neusspray, oplossing Xylometazoline hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Otrivin Menthol (without preservative) 1.0 mg/ml nasal spray, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 1.0 mg
More information1. NAME OF THE MEDICINAL PRODUCT. Vicks Sinex, 0.5 mg/ml, nasal spray solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1. NAME OF THE MEDICINAL PRODUCT Vicks Sinex, 0.5 mg/ml, nasal spray solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Oxymetazoline hydrochloride 0.5 mg/ml 1 spray (50 l) contains approximately 25
More informationBIJSLUITER: INFORMATIE VOOR DE GEBRUIKER
BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER Xylozolin 0,5 mg/ml, neusspray, oplossing Xylometazoline hydrochloride 0.5 mg/ml Xylozolin 1 mg/ml, neusspray, oplossing Xylometazoline hydrochloride 1 mg/ml Read
More informationAzelastine Nasal Spray 1 mg / 1 ml
Package Leaflet: Information for the User Allergodil 0,1% nasal spray, solution Active substance: Azelastine hydrochloride Read all of this leaflet carefully because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. EPHEDRINE HCl STEROP 10mg/ml EPHEDRINE HCl STEROP 50mg/ml Solution for injection. Ephedrine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER EPHEDRINE HCl STEROP 10mg/ml EPHEDRINE HCl STEROP 50mg/ml Solution for injection Ephedrine Hydrochloride Read all of this leaflet carefully before you start using
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAAM VAN HET GENEESMIDDEL Xylozolin 0,5 mg/ml, neusspray, oplossing Xylozolin 1 mg/ml, neusspray, oplossing Xylometazoline hydrochloride 1 / 0.5 mg/ml 2. QUALITATIVE
More informationDo not use Allergo-COMOD eye drops - if you are hypersensitive against sodium cromoglicate (Ph. Eur.) or one of the other ingredients.
Allergo-COMOD eye drops 20 mg/ml eye drops Active substance: Sodium cromoglicate (Ph. Eur.) Read all of this leaflet carefully because it contains important information for you. This medicine is available
More informationPackage leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine
Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always
More informationMETHYLDOPA 250 mg Film-coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More information1. What Octostim Nasal Spray is and what it is used for
Package Leaflet: Information for the User Octostim 1.5 mg/ml Nasal Spray Desmopressin acetate Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationAVIOMARIN 50 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER AVIOMARIN 50 mg tablets DIMENHYDRINATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationSUMMARY OF PRODUCT CHARACTERISTICS. 1 ml of nasal spray contains 0.5 mg of xylometazoline hydrochloride.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Nasonal 0,5 mg/ml neusspray, oplossing 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of nasal spray contains 0.5 mg of xylometazoline
More informationPackage leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate
Package leaflet: Information for the patient Brimonidine Biogaran 2 mg/ml eye drops, solution brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide
PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate
PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Otrivin Comp 0.5 mg/ml + 0.6 mg/ml nasal spray, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 0.5 mg xylometazoline
More informationPackage leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride
Package leaflet: Information for the patient / / 30 mg/5 ml syrup Ambroxol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the User Clarityn 10 mg tablets Loratadine
Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always
More informationPATIENT INFORMATION LEAFLET. Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine.
ALORES 2.5mg/5ml syrup For oral use only. PATIENT INFORMATION LEAFLET Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine. Excipients: Propylene glycol, sorbitol 70% (E420), citric
More informationPATIENT INFORMATION LEAFLET
N-CORT 0.055% Nasal Spray For nasal use. PATIENT INFORMATION LEAFLET Active substance(s): Triamcinolone acetonide (w/w%) 0.055 Excipient(s): Benzalkonium chloride 50%, sodium hydroxide, hydrochloric acid,
More informationTAFEN NASAL 50mcg nasal spray, suspension
PACKAGE LEAFLET: INFORMATION FOR THE USER TAFEN NASAL 50mcg nasal spray, suspension BUDESONIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Lidocaine Accord 10 mg/ml solution for injection Lidocaine Accord 20 mg/ml solution for injection Lidocaine hydrochloride Read all of this leaflet carefully before
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)
PACKAGE LEAFLET: INFORMATION FOR THE USER ZADITEN 1 mg/5 ml Oral Solution Ketotifen (as Ketotifen hydrogen fumarate) Read all of this leaflet carefully because it contains important information for you.
More information2 What you need to know before you use Beconase. Package Leaflet: Information for the user
Package Leaflet: Information for the user Beconase Aqueous Nasal Spray beclometasone dipropionate 50 micrograms Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationFlavamed Forte 30 mg/5 ml, oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Flavamed Forte 30 mg/5 ml, oral solution AMBROXOL HYDROCHLORIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationPackage leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride
MARKETING AUTHORISATION NO. 7810/2015/01-02-03-04 Annex 1 Package leaflet Package leaflet: Information for users Imodium 2 mg orodispersible tablets Loperamide hydrochloride Read all of this leaflet carefully
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)
PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationALPHAGAN EYE DROPS BRIMONIDINE TARTRATE
PACKAGE LEAFLET: INFORMATION FOR THE USER ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPACKAGE LEAFLET. Page 1 of 6
PACKAGE LEAFLET Page 1 of 6 Package leaflet: Information for the patient Procyclidine Hydrochloride 5 mg Tablets (procyclidine hydrochloride) Read all of this leaflet carefully before you start taking
More informationPackage Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)
Package Leaflet: INFORMATION FOR THE USER PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide) Read all of this leaflet carefully before you start taking this medicine because it contains
More informationHERNOVIR 200 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available
More informationNEW ZEALAND DATA SHEET
1. PRODUCT NAME Sudomyl, Tablet, 60 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Name and strength of the active substance Pseudoephedrine Hydrochloride 60mg Excipient(s) with known effect For the full
More informationPATIENT INFORMATION LEAFLET
N-CORT 0.055% nasal spray, suspension It is used by spraying into the nose. Active substance: (w/w%) Triamcinolone acetonide 0.055 PATIENT INFORMATION LEAFLET Excipients: Benzalkonium chloride 50%, sodium
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets
Package leaflet: Information for the patient Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets Acetylsalicylic acid Read all of this leaflet carefully before you
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Emerade 150 micrograms solution for injection in pre-filled pen Emerade 300 micrograms solution for injection in pre-filled pen Emerade 500 micrograms solution
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg/5 ml Oral Suspension fusidic acid Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)
More informationTRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.
TRIPROLIDINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains triprolidine. This leaflet is intended to provide information on the active ingredient
More informationPackage leaflet: Information for the patient. Metformin Actavis 500 mg and 850 mg filmcoated tablets. metformin hydrochloride
Package leaflet: Information for the patient Metformin Actavis 500 mg and 850 mg filmcoated tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for the patient. Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate)
Package leaflet: Information for the patient Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate) Read all of this leaflet carefully before you start taking this medicine because it
More informationProposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate
Proposed PIL NL/H/0653/001/IB/024/G PACKAGE LEAFLET: INFORMATION FOR THE USER MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Read all of this leaflet
More informationNAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.
NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon-A contains naphazoline hydrochloride
More informationPATIENT INFORMATION LEAFLET
ALORES 2.5mg/5ml Syrup For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml syrup (1 spoon) contains desloratadine 2.5 mg. Excipient(s): Propylene glycol, sorbitol 70%, citric acid
More informationColdrex MaxGrip Lemon Powder for oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Coldrex MaxGrip Lemon Powder for oral solution PARACETAMOL, PHENYLEPHRINE, ASCORBIC ACID This leaflet is a copy of the Summary of Product Characteristics and Patient
More informationPackage leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime
Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationALDOMET Film-coated Tablets 250 mg ALDOMET Film-coated Tablets 500 mg (Methyldopa)
PACKAGE LEAFLET: INFORMATION FOR THE USER ALDOMET Film-coated Tablets 250 mg ALDOMET Film-coated Tablets 500 mg (Methyldopa) Read all of this leaflet carefully before you start taking this medicine because
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone
PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES Lubiprostone This medicine is subject to additional monitoring. This will allow quick identification of new
More informationPackage leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.
Package leaflet: Information for the user Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate desmopressin Read all of this leaflet carefully before you start taking this medicine
More informationPackage leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride
Package leaflet: Information for the user Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient Triflu Paracetamol, Ascorbic Acid, Pheniramine Maleate 500 mg/200 mg/ 25 mg granules for oral solution in sachet Read all of this leaflet carefully before you
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.
What is in this leaflet PHENYLEPHRINE New Zealand Consumer Medicine Information The medicine you have purchased contains Phenylephrine. This leaflet is intended to provide information on the active ingredient
More informationPackage leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole
Package leaflet: Information for the user Zidoval 7.5 mg/g Vaginal Gel Metronidazole Read all of this leaflet carefully before you start using this medicine because it contains important information for
More informationTOULARYNX DEXTROMETHORPHAN FORTE 3 mg/ml, syrup Dextromethorphan HBr monohydrate
TOULARYNX DEXTROMETHORPHAN FORTE 3 mg/ml, syrup Dextromethorphan HBr monohydrate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPackage leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)
Package leaflet: Information for the patient Loratadine 10 mg Tablets (loratadine) Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage leaflet: Information for the user NON DROWSY SUDAFED. DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride
Package leaflet: Information for the user NON DROWSY SUDAFED DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)
PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More informationPackage leaflet: Information for the user. Lorastad 10 mg Tablets loratadine
Package leaflet: Information for the user Lorastad 10 mg Tablets loratadine [For medicines available only on prescription to be deleted if applicable:] Read all of this leaflet carefully before you start
More informationSanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets
Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets Pizotifen (as malate) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it
More informationXYZAL 5 MG FILM-COATED TABLET
XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate
PACKAGE LEAFLET: INFORMATION FOR THE USER SODIPHOS 22mEq / 10ml Concentrate for solution for infusion Disodium phosphate dihydrate Read all of this leaflet carefully before you start using this medicine.
More informationPackage Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost
Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it
More informationZofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.
Package Leaflet: Information for the User Zofran 4 mg/5 ml Syrup Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate
PACKAGE LEAFLET: INFORMATION FOR THE USER Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate Read all of this leaflet carefully before you start using this medicine. Keep
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More information1.3.1 PACKAGE LEAFLET: INFORMATION FOR THE USER
Fusidic acid 20 mg/g cream Page 1 of 6 1.3.1 PACKAGE LEAFLET: INFORMATION FOR THE USER AffusineAffusine 20 mg/g cream Fusidic Acid Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)
PACKAGE LEAFLET: INFORMATION FOR THE USER DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral) Read all of this leaflet carefully before you start using
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone
PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You
More informationTREANA 5mg and 10mg Film-coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER TREANA 5mg and 10mg Film-coated Tablets OLANZAPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationNORVASC 5 mg and 10 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationRisk What is known Preventability Increased symptoms of congestion when the effects of
VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Nasal congestion Nasal congestion and rhinorrhoea (runny nose) are symptoms that commonly occur together. The most common causes
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need
More informationPRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets
PRODUCT INFORMATION SUDAFED Sinus 12 Hour Relief Tablets NAME OF THE MEDICINE Pseudoephedrine Hydrochloride CAS 2 Registry Number: 345-78-8 DESCRIPTION SUDAFED Sinus 12 Hour Relief prolonged-release tablets
More informationFLUIMUKAN PLUS 600 mg effervescent tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER FLUIMUKAN PLUS 600 mg effervescent tablets Acetylcysteine This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for
More informationBenylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine
Benylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine This medicine is used to help relieve children s dry cough and cold symptoms. This medicine is for use by children
More informationZofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.
GlaxoSmithKline (logo) Package Leaflet: Information for the User Zofran 4 mg/5 ml Syrup Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Perfan Injection 100 mg/20 ml Concentrate for Solution for Injection Active substance: enoximone Read all of this leaflet carefully before you
More information1. What Naropin is and what it is used for
Package leaflet: Information for the user Naropin 2 mg/ml, 7.5 mg/ml, 10 mg/ml solution for injection Naropin 2 mg/ml solution for infusion Ropivacaine hydrochloride Read all of this leaflet carefully
More informationPackage Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)
Package Leaflet : Information for the User IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You
More informationPackage leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)
Package leaflet: Information for the user Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol) Read all of this leaflet carefully before you start taking this medicine because
More information2. What you need to know before you take DDAVP/Desmopressin Tablets
Package Leaflet: Information for the user DDAVP /Desmopressin 0.1mg Tablets Desmopressin Acetate Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPACKAGE LEAFLET. Page 1 of 8
PACKAGE LEAFLET Page 1 of 8 Package leaflet: Information for the patient Temazepam 10mg and 20mg tablets (Temazepam) Read all of this leaflet carefully before you start taking this medicine because it
More informationDorzolamide 20 mg/ml Eye Drops, Solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride
Package leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains
More informationRABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER DIAZEPAM 5mg/ 10mgRECTAL SOLUTION
PACKAGE LEAFLET: INFORMATION FOR THE USER DIAZEPAM 5mg/ 10mgRECTAL SOLUTION The name of your medicine is Diazepam rectal solution, which will be referred to as Diazepam or Diazepam solution throughout
More informationHavrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe
GSK (logo) Package Leaflet: Information for the User Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed). 1440 ELISA Units/1 ml Suspension for Injection in a pre-filled syringe Read all
More informationPackage leaflet: Information for the patient
Page 1 of 5 Package leaflet: Information for the patient Xyzal 5 mg/ml oral drops, solution For adults and children aged 2 years and above Levocetirizine dihydrochloride Read all of this leaflet carefully
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Lidokain Isdin 40 mg/g cream. Lidocaine
PACKAGE LEAFLET: INFORMATION FOR THE USER Lidokain Isdin 40 mg/g cream Lidocaine Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER 250 mg film-coated tablets. 500 mg film-coated tablets. 750 mg film-coated tablets. 1000 mg film-coated tablets. Levetiracetam
More information